Business

TRxADE HEALTH to Report Third Quarter 2021 Financial Results on Monday, October 25th at 5:00 p.m. Eastern Time

TAMPA, FL / ACCESSWIRE / October 11, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy

articleScienture Holdings, Inc.October 11, 20215/company/scienture-holdings-inc/news/trxade-health-to-report-third-quarter-2021-financial-results-on-monday-october-25th-at-500-pm-eastern-time
TRxADE HEALTH to Report Third Quarter 2021 Financial Results on Monday, October 25th at 5:00 p.m. Eastern Time

About this update from Scienture Holdings, Inc.

[{"type":"text","content":"TAMPA, FL / ACCESSWIRE / October 11, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the third quarter of 2021, after market close on October 25, 2021.Management will host a conference call on Monday, October 25, 2021 at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's third quarter 2021 financial results. The call will conclude with Q&A from participants.To participate, please use the following information:Q3 2021 Conference Call and WebcastDate: Monday, October 25, 2021Time: 5:00 p.m. Eastern timeU.S. Dial-in: 1-877-425-9470International Dial-in: 1-201-389-0878Conference ID: 13723384Webcast: http://public.viavid.com/index.php?id=146615Please dial in at least 10 minutes before the start of the call to ensure timely participation.A playback of the call will be available through November 25, 2021. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13723384. A webcast will also be available for 30 days on the IR section of the TRxADE HEALTH website or by clicking the webcast link above.About TRxADE HEALTH, INC.TRxADE HEALTH (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,700+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For info on TRxADE HEALTH, please visit the Company's IR website at investors.trxadegroup.com.Forward-Looking StatementsThis press release may contain forward-looking statements, including information about management's view of TRxADE's future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the \"Act\"). In particular, when used in the preceding discussion, the words \"may,\" \"could,\" \"expect,\" \"intend,\" \"plan,\" \"seek,\" \"anticipate,\" \"believe,\" \"estimate,\" \"predict,\" \"potential,\" \"continue,\" \"likely,\" \"will,\" \"would\" and...

More updates from Scienture Holdings, Inc.